- Home
- PLRZ vs HKPD Comparison
PLRZ vs HKPD Comparison
Compare PLRZ & HKPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLRZ
- HKPD
- Stock Information
- Founded
- PLRZ 2005
- HKPD 2016
- Country
- PLRZ Israel
- HKPD Hong Kong
- Employees
- PLRZ N/A
- HKPD N/A
- Industry
- PLRZ
- HKPD Other Pharmaceuticals
- Sector
- PLRZ
- HKPD Health Care
- Exchange
- PLRZ NYSE
- HKPD Nasdaq
- Market Cap
- PLRZ 14.7M
- HKPD 11.9M
- IPO Year
- PLRZ 2024
- HKPD 2025
- Fundamental
- Price
- PLRZ $0.01
- HKPD $1.01
- Analyst Decision
- PLRZ
- HKPD
- Analyst Count
- PLRZ 0
- HKPD 0
- Target Price
- PLRZ N/A
- HKPD N/A
- AVG Volume (30 Days)
- PLRZ 77.7M
- HKPD 275.2K
- Earning Date
- PLRZ 02-15-2025
- HKPD 01-01-0001
- Dividend Yield
- PLRZ N/A
- HKPD N/A
- EPS Growth
- PLRZ N/A
- HKPD N/A
- EPS
- PLRZ N/A
- HKPD 0.21
- Revenue
- PLRZ N/A
- HKPD $20,770,344.00
- Revenue This Year
- PLRZ N/A
- HKPD N/A
- Revenue Next Year
- PLRZ N/A
- HKPD N/A
- P/E Ratio
- PLRZ N/A
- HKPD $5.01
- Revenue Growth
- PLRZ N/A
- HKPD 32.91
- 52 Week Low
- PLRZ $0.25
- HKPD $0.88
- 52 Week High
- PLRZ $4.80
- HKPD $3.79
- Technical
- Relative Strength Index (RSI)
- PLRZ N/A
- HKPD N/A
- Support Level
- PLRZ N/A
- HKPD N/A
- Resistance Level
- PLRZ N/A
- HKPD N/A
- Average True Range (ATR)
- PLRZ 0.00
- HKPD 0.00
- MACD
- PLRZ 0.00
- HKPD 0.00
- Stochastic Oscillator
- PLRZ 0.00
- HKPD 0.00
About PLRZ POLYRIZON LTD
Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. Its technology platforms are Capture & Contain and Trap & Target.
About HKPD Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and (ii) OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.